Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)

Ads

You May Also Like

genedrive to release Genedrive® Connect mobile app

For release: 2 October genedrive plc ("genedrive" or the "Company") genedrive to release Genedrive® ...

AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

ALBANY, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of ...

Corvus Pharmaceuticals to Present at SITC’s 31st Annual Meeting

BURLINGAME, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage ...